NIJMEGEN, Netherlands & AARHUS, Denmark--(BUSINESS WIRE)--Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.
